2018
$70M
from 12 investors over 12 rounds
Remix Therapeutics raised $70M on May 17, 2022
Investors: The Column Group, Foresite Capital, Atlas Venture, Surveyor Capital, ARCH Venture Partners and Casdin Capital, LLC
Remix Therapeutics raised $65M on December 8, 2020
Investors: ARCH Venture Partners, Atlas Venture, Foresite Capital and The Column Group
Remix Therapeutics raised $16M on January 1, 2019
Investors: The Column Group and Atlas Venture